Research!America

Transforming the current disease-specific non-profit funding model and the outlook for FY16 budget levels for research were among the topics addressed by Alex Silver, chairman and co-founder of EB Research Partnership and Representative Chris Van Hollen (MD-08) at Research!America’s Annual Members meeting held at the Ronald Reagan Building in Washington, D.C. on March 11.

Current FOSEP leaders: Renee Agatsuma, Cyan James, Bish Paul, Abigail G. Schindler, PhD, Corey Snelson, PhD, Christopher Terai. (James and Schindler are the main authors)

Dear Research Advocate:

The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word!

Dear Research Advocate:

LOW PERCENTAGE HEAR ABOUT CLINICAL TRIALS FROM HEALTH CARE PROVIDERS

By Benjamin Caballero MS, PhD Candidate, Department of Developmental and Molecular Biology, Albert Einstein College of Medicine

Mary on Aljazeera government shutdown 10-18-13

Glenn Close, Dr. Leroy Hood, Dr. Reed Tuckson, Kathy Giusti and the Progeria Research Foundation to Receive 2014 Research!America Advocacy Awards

Dear Research Advocate:

SamNext Monday, October 21 at 9:00 pm EST, HBO will debut LIFE ACCORDING TO SAM, the story of Sam Berns, a young boy with an extremely rare and highly-rapid aging disease called Progeria, and his family’€™s 13-year fight to find a cure.

Pages

Subscribe to RSS - Research!America